Virtus Biotech ETF · $132M$20,310
BBPBBP vsXBIXBIState Street SPDR S&P Biotech ETF · $10.5B$12,576
$10,000 five years ago, dividends reinvested · they hold 47.0% in common
BBPMeasureXBI
Returns · dividends reinvested
+29.5%Year to dateJan 1 → Nov 3+27.2%
+38.7%1 yearTotal return+38.1%
+31.7%3 years · per year$10,000 became $22,842 · $24,320+34.5%
+15.2%5 years · per year$10,000 became $20,310 · $12,576+4.7%
Cost and income
0.34%Expense ratio$34 · $35 a year on $10k · lower is better0.35%
0.00%Trailing 12-mo yield$0 · $35 a year on $10k0.35%
Risk · past year
−9.4%Worst dropSmaller is better−14.9%
26.5%VolatilityLower is calmer29.1%
BBPXBI Winner of the row, in its colourEach row: the bigger of the two fills its side
6–2BBP wins
End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns